ARTICLE SUMMARY:
Privately held Surefire Medical believes its expandable-tip drug-delivery catheter can improve the odds for patients with liver cancer and certain other solid tumors. The device creates a pressure gradient inside a tumor-feeding artery, which drives embolization microspheres and other complex therapies deep into the tumor while protecting adjacent healthy tissues. But the possibilities don’t end there.
Privately held Surefire Medical Inc. believes it has found a way to improve the odds for patients with liver cancer and certain other solid tumors with its unique, expandable-tip drug-delivery microcatheter.
